stoxline Quote Chart Rank Option Currency Glossary
  
Omnicell, Inc. (OMCL)
27.91  0 (0%)    06-17 16:00
Open: 27.91
High: 28.44
Volume: 444,526
  
Pre. Close: 27.91
Low: 26.63
Market Cap: 1,282(M)
Technical analysis
2024-06-17 5:25:31 PM
Short term     
Mid term     
Targets 6-month :  35.93 1-year :  38.98
Resists First :  30.76 Second :  33.38
Pivot price 30.17
Supports First :  26.53 Second :  22.07
MAs MA(5) :  28.29 MA(20) :  30.59
MA(100) :  29.08 MA(250) :  40.63
MACD MACD :  -0.6 Signal :  -0.1
%K %D K(14,3) :  14.3 D(3) :  10.7
RSI RSI(14): 37.4
52-week High :  75.06 Low :  25.69
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ OMCL ] has closed above bottom band by 16.9%. Bollinger Bands are 64.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 28.48 - 28.61 28.61 - 28.75
Low: 26.24 - 26.41 26.41 - 26.57
Close: 27.59 - 27.86 27.86 - 28.14
Company Description

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Headline News

Mon, 17 Jun 2024
Omnicell, Inc. (NASDAQ:OMCL) Shares Bought by Greenwood Capital Associates LLC - Defense World

Sun, 16 Jun 2024
Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price - Simply Wall St

Fri, 14 Jun 2024
Omnicell (NASDAQ:OMCL) Stock Price Down 5.6% - MarketBeat

Thu, 13 Jun 2024
Omnicell (OMCL) Q2 Earnings Top Estimates, 2021 EPS View Up - Yahoo Singapore News

Wed, 12 Jun 2024
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Rating of “Hold” from Analysts - Defense World

Wed, 12 Jun 2024
Caxton Associates LP Takes $2.12 Million Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 46 (M)
Shares Float 43 (M)
Held by Insiders 1.5 (%)
Held by Institutions 102.9 (%)
Shares Short 2,010 (K)
Shares Short P.Month 2,370 (K)
Stock Financials
EPS -0.47
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 25.87
Profit Margin -2 %
Operating Margin -7.6 %
Return on Assets (ttm) -0.9 %
Return on Equity (ttm) -1.9 %
Qtrly Rev. Growth -15.4 %
Gross Profit (p.s.) 0
Sales Per Share 23.95
EBITDA (p.s.) 0.61
Qtrly Earnings Growth 0 %
Operating Cash Flow 218 (M)
Levered Free Cash Flow 153 (M)
Stock Valuations
PE Ratio -60.68
PEG Ratio 2.2
Price to Book value 1.07
Price to Sales 1.16
Price to Cash Flow 5.87
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android